Patent: Dual Function Proteins for Treating Metabolic Disorders

Author(s)

Brian R. Boettcher, Novartis Institutes for BioMedical Research
Shari L. Caplan, Novartis Institutes for BioMedical Research
Susan E. Cellitti, Novartis Institute for Functional Genomics
Douglas S. Daniels, University of DaytonFollow
Norio Hamamatsu, Novartis Institutes for BioMedical Research
Bernhard Hubert Geierstanger, Novartis Institute for Functional Genomics
Stuart Licht
Andreas Loew, Novartis Institutes for BioMedical Research
Stephen Craig Weldon, Novartis Institutes for BioMedical Research

Document Type

Article

Publication Date

4-4-2013

Publication Source

World Intellectual Property Organization

Abstract

The present invention relates to new proteins comprising fibroblast growth factor 2 1 (FGF21 ) and other metabolic regulators known to improve metabolic profiles in subjects to whom they are administered.

Document Version

Published Version

Comments

International Publication No.: WO 2013/049234 A2

eCommons Citation

Boettcher, Brian R.; Caplan, Shari L.; Cellitti, Susan E.; Daniels, Douglas S.; Hamamatsu, Norio; Geierstanger, Bernhard Hubert; Licht, Stuart; Loew, Andreas; and Weldon, Stephen Craig, "Patent: Dual Function Proteins for Treating Metabolic Disorders" (2013). Chemistry Faculty Publications. 103.
https://ecommons.udayton.edu/chm_fac_pub/103